Cellular and Molecular Mechanisms of Fungal Sepsis in the Critically Ill Patient
危重患者真菌性脓毒症的细胞和分子机制
基本信息
- 批准号:9906948
- 负责人:
- 金额:$ 28.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-08-15 至 2022-04-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAdultAgeAgingAntibiotic TherapyAntibioticsAntifungal AgentsAspergillus fumigatusCandidaCandida albicansCandidiasisCell WallCellsClinicalClinical DataComplexCritical IllnessDataDefectDiagnosisDiseaseExposure toGenderGlucansHost DefenseHumanImmuneImmune responseImmunocompetentImmunologicsImmunosuppressionIncidenceIndividualInfectionInjuryKnowledgeLength of StayLeukocytesLifeLiteratureMediatingMedical DeviceMembraneMolecularMycosesNatural ImmunityOperative Surgical ProceduresOutcomePatientsPattern recognition receptorPeripheral Blood Mononuclear CellPhysiologyPlayPredispositionProceduresPublishingResearchResistanceRiskRisk FactorsRoleSamplingSepsisSeptic ShockSignal TransductionTLR2 geneTestingage relatedagedbasecomorbiditydectin 1experimental studyfungushigh riskimmune functionindexingmortalitynovelpathogenic fungusperipheral bloodpreventreceptorreceptor bindingresponsesenescenceseptic patientssurvival outcome
项目摘要
Abstract
Invasive infections caused by opportunistic fungi are increasingly common in the surgical ICU.
The mortality rate for fungal sepsis in the ICU patient is 30-40%. It is well accepted that aging
plays a critical role in the incidence of sepsis and age is a known independent predictor of
mortality in sepsis. Fungal infections have become an increasing problem in older ICU patients.
This is due, in part, to the fact that sepsis results in immune suppression. However, it is also
known that healthy aged adults show senescence of immune function. In addition, aging
patients frequently have multiple co-morbidities and undergo more invasive procedures leading
to a higher risk of sepsis. The underlying cellular and molecular mechanisms that result in
increased susceptibility to fungal infection in the aged and/or septic patient are not fully
understood. The research outlined in this application is focused on addressing that deficit in our
knowledge. We have acquired preliminary data which demonstrate that healthy aged
individuals (>60 y.o.) show decreased anti-fungal Th17 mediated responses when compared to
young healthy controls. We also have preliminary data which indicate that clinical sepsis
decreases leukocyte expression of Dectin-1, the primary pattern recognition receptor for
induction of anti-fungal innate immunity. Based on these data and the published literature we
hypothesize that “susceptibility to fungal sepsis in the aged critically ill patient is mediated by
specific cellular and molecular defects in anti-fungal innate immunity”. To test our hypothesis we
propose the three following specific aims. In aim 1 we will identify the age related defects in
Dectin-1/Th17 dependent signaling in human leukocytes from healthy adults >60 y.o. We will
examine Dectin-1/Th17 mediated intracellular signaling in response to Candida albicans or C.
albicans cell wall glucan in leukocytes from adults >60 y.o. and compare them to those from
adults <30 y.o. In aim 2 we will identify defects in Dectin-1/Th17 dependent signaling in
leukocytes from patients with sepsis. In this aim we will critically evaluate Dectin-1/Th17
mediated signaling in response to Candida albicans or glucan in leukocytes from septic patients
and compare them to age matched healthy adults. In aim 3 we will investigate the impact of
clinical sepsis on human leukocyte Dectin-1 expression. We will correlate Dectin-1 expression
with the type of infection, acute physiology scores and injury indices, length of hospital stay,
days in ICU and survival outcome. These experiments will provide new knowledge of the
mechanisms that render the aged critically ill patient susceptible to life threatening fungal
infections. In addition, we will acquire new clinical data that may identify novel predictors of
susceptibility to fungal infection. Finally, we will investigate strategies to increase resistance to
opportunistic fungal infections in the critically ill patient.
摘要
机会性真菌引起的侵袭性感染在外科ICU中越来越常见。
ICU患者真菌性败血症的死亡率为30- 40%。人们普遍认为,
在脓毒症的发病率中起关键作用,年龄是已知的脓毒症的独立预测因子。
败血症死亡率。真菌感染已成为老年ICU患者日益严重的问题。
这部分是由于脓毒症导致免疫抑制的事实。但也
众所周知,健康的老年人表现出免疫功能的衰老。此外,
患者经常有多种合并症,并经历更多的侵入性手术,
患败血症的风险更高潜在的细胞和分子机制,导致
老年和/或脓毒症患者对真菌感染的易感性增加并不完全
明白本申请中概述的研究重点是解决我们在
知识我们获得的初步数据表明,健康的老年人
个人(>60岁)显示出降低的抗真菌Th 17介导的应答,
年轻的健康对照。我们也有初步的数据表明临床败血症
减少白细胞Dectin-1的表达,Dectin-1是白细胞的主要模式识别受体,
诱导抗真菌先天免疫。根据这些数据和已发表的文献,
假设“老年重症患者对真菌性脓毒症易感性是由
抗真菌先天免疫中的特定细胞和分子缺陷”。为了验证我们的假设,
提出以下三个具体目标。在目标1中,我们将确定与年龄相关的缺陷,
来自>60岁健康成人的人白细胞中的Dectin-1/Th 17依赖性信号传导我们将
检测Dectin-1/Th 17介导的细胞内信号传导对白色念珠菌或念珠菌的应答。
>60岁成人白细胞中的白色念珠菌细胞壁葡聚糖并将它们与
成人<30岁在目标2中,我们将鉴定在细胞中Dectin-1/Th 17依赖性信号传导的缺陷。
脓毒症患者的白细胞为此,我们将严格评估Dectin-1/Th 17
脓毒症患者白细胞中响应白色念珠菌或葡聚糖的介导信号传导
并将其与年龄匹配的健康成年人进行比较。在目标3中,我们将研究
临床脓毒症对人白细胞Dectin-1表达的影响。我们将Dectin-1表达与
感染类型、急性生理学评分和损伤指数、住院时间,
ICU天数和生存结局。这些实验将提供新的知识
使老年重症患者易受危及生命的真菌感染的机制
感染.此外,我们将获得新的临床数据,这些数据可能会发现新的预测因子,
对真菌感染易感。最后,我们将研究增加对
危重病人的机会性真菌感染
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Tammy Regena Ozment其他文献
Tammy Regena Ozment的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Tammy Regena Ozment', 18)}}的其他基金
Equipment Supplement Requisition for Mesoscale Quick Plex SQ 120mm Reader
Mesoscale Quick Plex SQ 120mm 读取器的设备补充申请
- 批准号:
10173094 - 财政年份:2017
- 资助金额:
$ 28.86万 - 项目类别:
Cellular and Molecular Mechanisms of Fungal Sepsis in the Critically Ill Patient
危重患者真菌性脓毒症的细胞和分子机制
- 批准号:
9287076 - 财政年份:2017
- 资助金额:
$ 28.86万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 28.86万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 28.86万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 28.86万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 28.86万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 28.86万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 28.86万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 28.86万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 28.86万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 28.86万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 28.86万 - 项目类别:
Research Grant